Oncologic and cosmetic outcomes of oncoplastic breast-conserving surgery after neoadjuvant systemic therapy: systematic review and meta-analysis
- 14 December 2024
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 209 (2) , 229-252
Abstract
Purpose Oncoplastic breast-conserving surgery (OBCS) prevents compromise of breast aesthetics following large breast cancer excisions. This systematic review was conducted to investigate the outcomes (oncologic, surgical, cosmetic) of OBCS versus standard breast-conserving surgery (SBCS) and mastectomy post-neo-adjuvant systemic therapy. Methods Ovid, Web of Science, Cochrane, ClinicalTrials.gov databases were searched up to 24/08/2024. English language peer-reviewed RCTs or observational/cohort studies with ≥ 18-year-old women treated for breast cancer with neoadjuvant chemotherapy (NACT) and/or hormonal therapy comparing OBCS to SBCS and/or mastectomy were included. Of 6794 articles, 32 underwent full-text assessment and eleven met the inclusion criteria. The review was conducted using PRISMA guidelines. Two reviewers independently extracted data and assessed risk of bias (Newcastle-Ottowa Scale). Meta-analysis using a random-effects model were performed where data allowed. Results Eleven cohort studies (n = 4594) included OBCS (n = 912), SBCS (n = 1122) and mastectomy (n = 2560) after NACT. Post-NACT tumour size was 20(9–44) mm, 13(0–23)mm [SMD 0.62, 95%CI(−0.24,1.48), p = 0.16] and 20(10–31)mm [SMD 0.05, 95%CI(−0.53,0.63), p = 0.86] in the OBCS, SBCS and mastectomy groups respectively. The margin re-excision rate was significantly lower in OBCS than in SBCS [2.9%(0–11.1%) vs. 6.1%(0–18.5%); OR 0.35, 95%CI(0.15,0.80), p = 0.01]. All other oncologic outcomes, including positive margin rate, and overall survival, were not statistically different between the groups. Cosmetic outcomes and patient-reported outcome measures were marginally in favour of OBCS [OBCS 50–66% vs SBCS 37.6–55% very satisfied]. Conclusion OBCS after NACT appears oncologically safe and a potential alternative in patients with partial or poor tumour response to NACT. Further studies are required, directly comparing well-matched OBCS with SBCS and mastectomy patients after NACT.Keywords
Funding Information
- NIHR Cambridge Biomedical Research Centre (BRC 1215 20014)
- Addenbrooke's Charitable Trust, Cambridge University Hospitals (900353)
- NIHR (NIHR205746)
- UK Research and Innovation (10073066)
This publication has 40 references indexed in Scilit:
- Oncoplastic breast-conserving surgery for women with primary breast cancerCochrane Database of Systematic Reviews, 2021
- Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort studyBreast Cancer Research and Treatment, 2020
- Oncologic and Cosmetic Outcomes of Oncoplastic Breast Surgery in Locally Advanced Breast Cancer After Neoadjuvant Chemotherapy, Experience from a Developing CountryIndian Journal of Surgical Oncology, 2017
- Oncoplastic breast conservation surgery is oncologically safe when compared to wide local excision and mastectomyThe Breast, 2017
- The role of oncoplastic breast conserving treatment for locally advanced breast tumors. A matching case-control studyAnnals of Medicine & Surgery, 2016
- Evaluation of Surgical Outcomes of Oncoplasty Breast Surgery in Locally Advanced Breast Cancer and Comparison with Conventional Breast Conservation SurgeryIndian Journal of Surgical Oncology, 2016
- Neoadjuvant therapy and breast cancer surgery: a closer look at postoperative complicationsThe American Journal of Surgery, 2013
- The role of Oncoplastic Breast Surgery in the management of breast cancer treated with primary chemotherapyThe Breast, 2013
- The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic reviewInsights into Imaging, 2013
- Oncoplastic Techniques Extend Breast‐Conserving Surgery to Patients with Neoadjuvant Chemotherapy Response Unfit for Conventional TechniquesWorld Journal of Surgery, 2009